News Breaks |
|
|
| January 4, 2013 |
| 06:47 EDT |  | LGND | Ligand Pharmaceuticals downgraded to Hold from Buy at Cantor
Cantor downgraded Ligand Pharmaceuticals citing reduced expectations for Promacta in the Hepatitis C indication and few near-term data catalysts. The firm lowered its price target for shares to $23 from $28. |
|
|
News For LGND From The Last 14 Days Check below for free stories on LGND the last two weeks. |
|
|
| May 24, 2013 |
| 07:26 EDT |  | LGND | Ligand Pharmaceuticals management to meet with Roth Capital
Meeting to be held in Boston on May 30 hosted by Roth Capital. |
|
| May 15, 2013 |
| 11:06 EDT | | LGND | Ligand Pharmaceuticals management to meet with Roth Capital
 Subscribe for More Information |
|
|
|
|
|
